VALUE BASED CARE

Learn about our global commitment to improving the lives of kidney disease patients through interconnected intelligence.

Read about advancing interoperability to reduce provider burden and improve care for chronic kidney disease patients.

Len Usvyat, PhD, Vice President of Applied Advanced Analytics, joins Field Notes to explain how artificial intelligence is being used to provide better treatment for people with kidney disease by predicting potential outcomes and future health care needs.

Listen to Field Notes, a podcast by FMCNA. Dr. Ben Hippen joins to discuss the importance of improving the kidney transplant process for patients.

Listen to Field Notes, a podcast by FMCNA. Dr. Emel Hamilton joins us to share how FMCNA is improving kidney patient outcomes through information exchange.

Kim Sonnen and Dr. George Hart discuss how InterwellHealth is advancing value-based models of care to improve the outcomes for patients with kidney failure.

Michelle Carver discusses our home dialysis digital training platform, with separate educational experiences for both peritoneal dialysis and home hemodialysis.

The Comprehensive Kidney Care Choices (CKCC) model, aims to improve outcome and reduced costs for patients with kidney disease.

Casey Humphries discusses how making organs more accessible and available to patients in need is critical to successful transplants.

Dr. Murat Sor joins Field Notes to discuss how optimal starts can result in fewer complications, reduce costs, and improve outcomes for patients.

In this episode, Dr. Amaka Eneanya and Mignon Early discuss FMC's recent commitment to the Zero Health Gaps Pledge and its efforts to close gaps in care on an international level

Dr. Charles Herzog and Dr. Christopher Chan join this episode of Field Notes to talk about the American Heart Association's recent statement explaining how home dialysis can improve a patient's cardiovascular health and how prescribing dialysis with heart health in mind can increase the chances for successful care plans for patients.

Dr. Hippen discusses the challenges facing global transplant and why transplantation remains a vital therapy option for people with advanced kidney disease.

Nephrologist Kolitha Basnayake discusses how quality improvement programs must address barriers to shared hemodialysis care for the individual.

Dr. Jennifer Flythe discusses patient-related outcome measures and how they can improve the quality of kidney disease patient care.

Dr. Sumit Mohan joins this episode to discuss the importance of kidney transplantation and strategies to address inequities in kidney transplantation access.

In this episode of GMO Dialogues, Robert Sepucha, CEO of InterWell health talks about how this legislation changed the trajectory of kidney disease care in the United States, and led to value-based care models of today.

Learn how advanced analytics are used to collaborate and prioritize tools that can be meaningfully integrated into a clinician’s workflow.

Discover a new renal-focused genomic registry that will encourage more research in the underlying mechanisms of kidney disease and personalized medicine.

Learn how Fresenius Medical Care is reducing hurdles to transplantation and reducing kidney transplant waitlist time.

Learn about how InterWell and FMCNA are delivering value-based care to kidney disease patients.

Learn about some of the nonmedical factors that further complicate the lives and healthcare outcomes of CKD patients.

renal-healthcare-sustainability

We're taking a multifaceted approach to advancing transplantation including technologies to expand the pool of kidneys available for transplant.

The ability to take healthcare innovations and learnings from one locale to another has helped us make an impact in communities worldwide.

Cardiac disease prevention and management is one of the most important clinical targets in patients receiving maintenance dialysis.

Get to know Dr. Ahmad Sharif, MD, MPH, the Senior Vice President and Chief Medical Information Officer at Fresenius Medical Care North America.

Since March, Health and Human Services (HHS) Secretary Alex Azar placed value based care innovation on the top of his list of priorities. Read more.

Congress passed the Dialysis Access Improvement Act of 2017, allowing independent quality assurance organizations to issue accreditation. Learn more.

Greg Garza discusses value based care programs, reducing costs, and improving quality care for patients. Read more here.

Read about 5 end stage renal disease innovations helping transform the lives of kidney patients.

Read an interview with Dr. Dinesh Chatoth who is working to support the evolution and growth of home dialysis therapies.

Learn how nephrologists are being impacted by value based care and how MIPS and MACRA can help them get reimbursed for their services.

Read why FMCNA CEO Bill Valle and NxStage CEO Jeff Burbank brought their companies together to improve access to home dialysis.

Learn how we're supporting National Kidney Foundation, Health and Human Services Secretary Alex Azar in his efforts to advace value based care for CKD.

The Dialysis Patient Access to Integrated-care, Empowerment, Nephrologists, and Treatment Services (PATIENTS) Demonstration Act, would deliver high-quality, integrated care to patients receiving dialysis for the last stage of kidney failure called end-stage renal disease (ESRD). The bi-partisan proposal would establish an integrated care program where interdisciplinary teams, led by a nephrologist, provide holistic management for all of the patient's healthcare needs.

In this Q&A with Joe Turk, President of FMCNA’s Home and Critical Care Therapies, we discuss how TCUs are providing patients a smoother start into dialysis

A new predictive tool designed specifically to identify dialysis patients most at risk for hospitalization has been embraced by nurses who have come to see it as essential.

The 21st Century Cures Act created new insurance options for end stage renal disease patients now allowed to enroll in Medicare Advantage. Read more.

The (FMCNA) Medical Office highlights the top 5 innovations in kidney care to watch for in 2021, potentially transforming the lives of dialysis patients.

End stage renal disease treatment choices (ETC) Model to increase the number of patients receiving home dialysis or transplantation.

Pacific Cardiovascular Associates Medical Group, Inc. and FMCNA have partnered to expand their cardiovascular scope and patient base. Learn more.

Dr. Dugan Maddux shares how kidney supportive care is improving quality of life for ESRD patients. Read more about FMC’s dedication to patient-focused care.

Read more about how Fresenius Medical Care is advancing medicine using clinical trials in renal care..

Discover how pharmacists can take a lead role in delivering effective patient care services to improve medication adherence and optimize patient outcomes.

Revenue cycle management (RCM) is the process a healthcare provider uses to track patient service revenue from the time of account creation to the final payment.

Learn more about ESRD Seamless Care Organizations, or ESCOs, including the anticipated advantages and eligibility requirements.

Learn about our integrated health plans and services that focus on prevention, primary care, behavioral health, and managing chronic conditions.

Kidney transplant is the ideal treatment for patients with ESRD. Learn more about what is being done to improve patient's access to kidney transplantation.

In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) is used to measure healthcare quality. Learn more here.

Learn more about how the Fresenius Health Partners Clinical Interventions Lab evaluates and implements new interventions.

Learn more about how FMCNA has partnered with accountable care organizations to deliver innovative value based care.

Dr. Jeffrey Hymes shares how the "Bundle" has provided a stimulus to change clinical algorithms and has enhanced dialysis patient outcomes.

New partnership between Vantage Health Plan and Fresenius Medical Care North America is aimed at slowing the progression of chronic kidney disease.

The CKCC model incentivizes medical providers to manage the care of individuals with chronic kidney disease and end stage renal disease. Find out how.

Fresenius Medical Care announces a three-way merger between Fresenius Health Partners, InterWell Health, and Cricket Health.

Learn how social workers help patients interact with their care teams and thrive with chronic kidney disease.

The value based kidney care model is shaping the future of Nephrology by improving CKD and ESRD patient outcomes while reducing the cost of care.

Value based care models for kidney disease patients emphasize care options with lower costs and improved care. Learn about two recent models, ETC and KCC.

Learn how FMCNA is using artificial intelligence to improve care for people on dialysis and people living with CKD and ESRD.

Continuous Kidney Replacement Therapy, is a form of dialysis for critically ill patients with acute kidney injury. Learn about CKRT and the different modalities used.

Fresenius Medical Care North America is in the ideal position to drive innovation and translate science into patient care standards. Learn more.

Dr. Hippen discusses the challenges facing global transplant and why transplantation remains a vital therapy option for people with advanced kidney disease.

Nephrologist Kolitha Basnayake discusses how quality improvement programs must address barriers to shared hemodialysis care for the individual.

Dr. Jennifer Flythe discusses patient-related outcome measures and how they can improve the quality of kidney disease patient care.

Dr. Sumit Mohan joins this episode to discuss the importance of kidney transplantation and strategies to address inequities in kidney transplantation access.

In this episode of GMO Dialogues, Robert Sepucha, CEO of InterWell health talks about how this legislation changed the trajectory of kidney disease care in the United States, and led to value-based care models of today.

Learn how the next generation of value based care can offer patients less fragmented care, a broader choice of treatments, and improved outcomes over time.

Experts share why better kidney transplant access requires a vision and framework that mandates open communication and active collaboration.